Swine flu line eases pressure on GPs
By Tom Moberly, 31 July 2009
Pressure on GPs and out-of-hours services in England has been significantly cut by the introduction of the National Pandemic Flu Service, new data show.
RCGP and QSurveillance figures both show that daily GP consultation rates for influenza-like illness fell after the introduction of the service last week, England's chief medical officer Sir Liam Donaldson said at a briefing on Thursday.
PCTs have also reported drops in the demand on their out-of-hours services, he said. The number of cases managed by PCTs in London almost halved after the introduction of the National Pandemic Flu Service.
Around 150,000 people have been given antiviral treatment through the service, Sir Liam added.
Those accessing the service were split equally between those using the internet and those using the phone service, he said.
VISIT OUR SWINE FLU RESOURCE CENTRE
More news from 31 July
GMC set for £3.5m windfall after charging over-65s
GP MP to stand down at next election
Assisted suicide and palliative care 'can work together'
Additional Information
Latest jobs Jobs web feed
- Salaried GP The Practice plc £75-85k FTE +NHS pension, Ely or Leicester
- Regional Clinical Leads The Practice plc Salary £95-105k FTE + NHS pension, Leicester or Sheffield
- Salaried/Lead GPs Malling Health Competitive, role dependant, NHS Pension and defence fees reimbursed, Nationwide
- Newly qualified GP's dr-locums £70 an hour plus, Nationwide
- Full Time Partner (9 sessions) Charnwood Community Medical Group Equal share partner, Loughborough, LEICS
- Locum GP Meddoc Locums £600-£800 A day, London & Essex
Most read
- Health secretary says GPs have 'ethical duty' to save NHS costs
- GPs face 'outcomes targets overload', patient group warns
- LMCs Conference 2012 - Live Blog
- QOF errors trigger £1,000 top ups and clawbacks
- Women to be screened later for cervical cancer in Scotland and Wales
- LMCs conference 2012 - Full coverage
Most commented
MIMS Drug Search
Possible searches include drugs (by brand, generic ingredient or drug class), diseases and more.
